ImmunoGen Announces Departure of Anna Berkenblit, Chief Medical Officer
ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that Anna Berkenblit, MD, Senior Vice President and Chief Medical Officer,...
Mark Enyedy Michael Vasconcelles Anna Berkenblit Immunogen Inc Immunogen Executive Committee Senior Vice President
Source: marketscreener.com